{
  "ptid_time": "099_S_4086_2013-09-11",
  "img_path": "/data/qiuhui/data/adni/images/099_S_4086/2013-09-11/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 74,079 mm³, 57.6% above the reference mean. With a Z-score of 1.67 (95.3th percentile), this represents moderate enlargement; hippocampal volume measures 6,239 mm³, 10.5% below the reference mean. With a Z-score of -0.90 (18.3th percentile), this represents normal volume ; whole brain volume measures 757,587 mm³, 26.4% below the reference mean. With a Z-score of -3.46 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 83.8 years. Gender is Male. Education: 20 years. MMSE: 25.0. MoCA: 25.0. Logical Memory: 13.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.39 SUVR (significant elevated); Amyloid beta: 827.30 pg/mL (normal ); Total tau: 112.10 pg/mL (moderate reduced); Phosphorylated tau: 8.87 pg/mL (moderate reduced). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound whole brain atrophy and moderate ventricular enlargement, which are indicative of significant neurodegeneration. However, hippocampal volume is within normal limits, and cognitive scores (MMSE, MoCA) are borderline normal, with normal Aβ but elevated AV45 (amyloid PET) and reduced tau markers, suggesting possible non-AD pathology or early-stage changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting biomarkers and preserved hippocampal volume despite significant atrophy elsewhere)",
  "timestamp": "2025-07-26T11:05:42.464337"
}